Semglee 100 IU/ml Injection is a long-acting insulin analog designed for the management of diabetes mellitus in adults, adolescents, and children. It contains Insulin Glargine, which provides a steady, peakless insulin profile, mimicking the body’s basal insulin secretion over a 24-hour period. Semglee is suitable for type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), either as monotherapy or in combination with other insulin formulations or oral antidiabetic agents.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Semglee Injection is indicated for:

• Type 1 diabetes mellitus (T1DM) for basal insulin replacement

• Type 2 diabetes mellitus (T2DM) requiring long-acting insulin for glycemic control

• Combination therapy with short-acting insulins or oral hypoglycemic agents when diet, exercise, or single therapy is insufficient

The injection helps maintain steady blood glucose levels, preventing hyperglycemia between meals and overnight.

Pharmacology and Mode of Action

Insulin Glargine is a recombinant human insulin analog that differs from regular human insulin by modifications in its amino acid sequence. These changes:

1. Reduce solubility at physiological pH, forming microprecipitates in subcutaneous tissue after injection

2. Allow slow and sustained release of insulin into the bloodstream

3. Provide a flat, peakless profile over approximately 24 hours

Semglee binds to insulin receptors, facilitating glucose uptake in skeletal muscles and adipose tissue, inhibiting hepatic glucose production, and regulating lipid and protein metabolism.

Dosage and Administration

• Adults and children: Dosage is individualized based on blood glucose levels, body weight, diet, and other antidiabetic therapy

• Typical starting dose:

  • T1DM: Approximately one-third of total daily insulin requirement

  • T2DM: Usually 10 units once daily or 0.2 units/kg once daily

• Administer subcutaneously once daily at the same time each day, preferably in the abdomen, thigh, or upper arm

• Do not shake the vial or pen vigorously; roll gently to mix

• Monitor blood glucose regularly and adjust the dose to maintain target glycemic control

Drug Interactions

• Drugs affecting insulin sensitivity or glucose metabolism may alter Semglee’s effect

• Corticosteroids, diuretics, sympathomimetics, thyroid hormones may increase insulin requirements

• Beta-blockers, ACE inhibitors, alcohol, or sulfonylureas may enhance insulin effect and increase risk of hypoglycemia

Contraindications

Semglee Injection should not be used in patients with:

• Hypersensitivity to Insulin Glargine or any component of the formulation

• Hypoglycemia at the time of injection

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects include:

• Hypoglycemia, the most frequent adverse effect

• Local injection site reactions such as redness, swelling, or itching

• Rare: allergic reactions, weight gain, or lipodystrophy at injection sites

Precautions and Warnings

• Adjust dose carefully in renal or hepatic impairment

• Monitor blood glucose and ketone levels during illness or stress

• Rotate injection sites to reduce risk of lipodystrophy

• Use caution during pregnancy and lactation; only adjust under medical supervision

Pregnancy and Lactation

• Insulin Glargine is preferred during pregnancy when diet alone is insufficient, as it does not cross the placenta in significant amounts

• Unknown if excreted in breast milk; use with caution in nursing mothers

Storage Conditions

• Store unopened vials/pens in a refrigerator (2–8°C)

• Protect from light and freezing

• Once opened, vials/pens can be kept below 30°C for up to 28 days

• Keep out of reach of children.